Is Intramuscular Injection of 10 mg Biotin Safe?
Yes, intramuscular injection of 10 mg biotin is safe and well within established therapeutic ranges, with no toxicity concerns at this dose.
Safety Profile Based on Guidelines
The 2022 ESPEN Micronutrient Guidelines 1 provide clear evidence that biotin has an excellent safety profile:
- No upper limit (UL) has been established for biotin toxicity 1
- No adverse effects have been documented for oral or IV administration of pharmacological doses up to 5 mg/day for prolonged periods 1
- For biotin deficiency treatment, oral doses of 10 mg/day are specifically recommended for patients with malabsorption and short bowel syndrome 1
- In severely deficient parenteral nutrition-dependent patients, IV doses up to 200 mg/day for 2-3 weeks have been safely used 1
Clinical Context for 10 mg IM Dose
Your proposed 10 mg IM dose falls well within documented safe ranges:
- Standard PN recommendations: 60 mcg/day (Grade B recommendation) 1
- Therapeutic oral dosing: 10 mg/day for malabsorption 1
- High-dose IV therapy: Up to 200 mg/day safely administered 1
The 10 mg IM dose represents only 5% of the maximum therapeutic IV dose that has been safely used in clinical practice.
Supporting Evidence
Research confirms safety at comparable doses:
- A 2022 study 2 demonstrated safety and efficacy of 5 mg biotin IM injections weekly for 6 weeks in treating diffuse hair loss, with no adverse reactions reported
- A 1980 study 3 showed that single IM multivitamin injections (including biotin) were safe and more effective than oral supplementation in elderly patients
- Toxicology studies 4 established a NOAEL of 600 mg/kg/day in rats, which equates to approximately 39 grams/day for a 70 kg human—far exceeding any clinical dose
Important Caveats
Laboratory interference warning:
- High-dose biotin supplementation (≥10 mg/day) can interfere with immunoassays that use biotin-streptavidin technology 5
- This can cause falsely abnormal results for thyroid function tests, parathyroid hormone, vitamin D, troponin, and other critical lab values
- Advise patients to discontinue biotin 72 hours before laboratory testing if possible
- Inform ordering physicians about biotin supplementation to prevent misinterpretation of results
Route of Administration
While the guidelines primarily discuss oral and IV routes 1, the IM route is appropriate when:
- Oral absorption is compromised
- IV access is not available or practical
- Rapid tissue saturation is desired
The 1980 study 3 specifically demonstrated that IM administration promotes better tissue saturation compared to oral supplementation, particularly in patients with potential malabsorption issues.
Practical Recommendation
Proceed with 10 mg IM biotin injection safely, ensuring:
- Proper sterile technique for IM administration
- Documentation of biotin supplementation in the medical record
- Patient education about potential laboratory test interference
- Instruction to inform healthcare providers and laboratories about biotin use before any blood work